ArticleRSC advances2021
Positional isomeric effect of monobrominated ending groups within small molecule acceptors on photovoltaic performance.
Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As an ending acceptor unit (A) within acceptor-donor-acceptor (A-D-A)-type small molecule acceptors (SMAs), monobrominated 1,1-dicyanomethylene-3-indanone (IC-Br) plays a critical role on developing high-performance SMAs and polymer acceptors from polymerizing SMAs. IC-Br is usually a mixture (IC-Br-m) consisting of positional isomeric IC-Br-γ and IC-Br-δ (bromine substituted on the γ and δ positions, respectively). The positional isomeric effect of these monobrominated ending groups has been witnessed to take an important role on regulating the photovoltaic performance. Fully investigating this isomeric effect of monobromination would be of great value for SMAs and even polymer acceptors. In this study, benefitting from the separation of IC-Br-γ and IC-Br-δ from IC-Br-m with high yields, bis(thieno[3,2-
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.